Company profile for Lava Therapeutics

PharmaCompass

Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

Update your Virtual Booth on PharmaCompass, ask us

About

Lava Therapeutics B.V. is a biotechnology company, founded in 2016, that creates and develops next generation γδ T cell engaging bispecific antibodies for the treatment of cancer. Our first-in-class immuno-oncology approach activates γδ T cells in a tumor target dependent manner. The objective of Lava Therapeutics B.V is to develop potent, safe and cost-effective biopharmaceuticals that arm the immune system to recognize a...
Lava Therapeutics B.V. is a biotechnology company, founded in 2016, that creates and develops next generation γδ T cell engaging bispecific antibodies for the treatment of cancer. Our first-in-class immuno-oncology approach activates γδ T cells in a tumor target dependent manner. The objective of Lava Therapeutics B.V is to develop potent, safe and cost-effective biopharmaceuticals that arm the immune system to recognize and destroy tumor cells.

List your booth number for exhibitions, ask us

CONTACT DETAILS

Click the arrow to open the dropdown
Country
Country
Netherlands
Address
Address
Yalelaan 60 5th floor Utrecht, Utrecht 3584 CM
Telephone
Telephone
+31 6 3000 3035
youtube
YouTube
Twitter
Twitter

Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

Events

Webinars & Exhibitions

Default Event

DDL Conference

Not Confirmed

envelop Contact Supplier

DDL Conference

Post an Enquiry

Meeting

Digital content

Create Content with PharmaCompass, ask us

NEWS #PharmaBuzz

read-more
read-more

https://www.globenewswire.com/news-release/2025/11/21/3192735/7281/en/XOMA-Royalty-Announces-Closing-of-Transactions-to-Acquire-LAVA-Therapeutics-N-V.html

GLOBENEWSWIRE
21 Nov 2025

https://www.globenewswire.com/news-release/2025/11/13/3187198/0/en/LAVA-Announces-Exceeding-Minimum-Condition-in-Tender-Offer-and-Intent-to-Delist-from-Nasdaq.html

GLOBENEWSWIRE
13 Nov 2025

https://www.globenewswire.com/news-release/2025/11/10/3185048/0/en/LAVA-Therapeutics-N-V-Shareholders-are-Reminded-to-Tender-Shares-for-XOMA-Royalty-Transaction-Before-November-12-2025-Deadline.html

GLOBENEWSWIRE
10 Nov 2025
Xoma And Lava Buyout Cools With Lower Offer
Xoma And Lava Buyout Cools With Lower Offer

17 Oct 2025

// FIERCE BIOTECH

https://www.fiercebiotech.com/biotech/xoma-and-lava-cool-buyout-lowering-both-cash-offer-and-closing-conditions

FIERCE BIOTECH
17 Oct 2025

https://www.globenewswire.com/news-release/2025/10/02/3160726/7281/en/XOMA-Royalty-Extends-Tender-Offer-to-Acquire-LAVA-Therapeutics-N-V.html

GLOBENEWSWIRE
02 Oct 2025

https://www.globenewswire.com/news-release/2025/09/30/3158434/0/en/LAVA-Therapeutics-to-Move-Extraordinary-General-Meeting-to-Early-November-2025.html

GLOBENEWSWIRE
30 Sep 2025

REF. STANDARDS & IMPURITIES

Upload your portfolio for free, ask us

ABOUT THIS PAGE

Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty